Rob Franciscus Martinus Verhagen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rob Franciscus Martinus Verhagen has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Annelot Clementine Mathilda van Esbroeck
Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands
1 shared publication - Ben Distel
Department of Clinical Genetics, Erasmus MC, Rotterdam, 3015 GD, The Netherlands / ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC, Rotterdam, 3015 GD, The Netherlands
1 shared publication - Martina Biagioni
IRCCS Humanitas Clinical and Research Center
1 shared publication - Matteo Fossati
Institute of Neuroscience - CNR
1 shared publication - Ype Elgersma
Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands
1 shared publication
Latest Publications
- Open Access
Localization of Human UBE3A Isoform 3 is Highly Sensitive to Amino Acid Substitutions at p.Met21 Position
UBE3A encodes three isoforms of Ubiquitin E3 ligase A, which differ in their N-terminal sequence, abundance, and localization. Recently, three individuals diagnosed with Angelman Syndrome have been described who carry a variant that abrogates the start codon of the predominant nuclear isoform 1 (hUBE3A-Iso1 p.Met1Thr ) and concomitantly results in a missense variant in isoform 3 (hUBE3A-Iso1 p.Met21Thr ), which we previously reported to be nuclear enriched as well. Here, we studied the effect of the p.Met21Thr variant on hUBE3A-Iso3 localization. Recombinant expression of hUBE3A-Iso3 p.Met21Thr in U2-OS and mouse neurons revealed similar UBE3A labelling in the nucleus and cytosol, indicating hUBE3A-Iso3 localization is sensitive to amino acid changes at this position. This finding prompted us to revisit hUBE3A-Iso3 localization, since we previously introduced a p.Met21Ala/p.Met22Ala amino acid substitution in hUBE3A-Iso3 and its mouse orthologue mUBE3A-Iso2 to prevent translation of the shorter hUBE3A-Iso1 and mUBE3A-Iso3 nuclear isoforms. Introduction of silent mutations to disfavour translation of the short UBE3A isoforms enabled us to determine the localization hUBE3A-Iso3 and mUBE3A-Iso2 in the absence of amino acid changes at the p.Met21/p.Met22 position, respectively. Surprisingly, hUBE3A-Iso3 localization shifted from predominant nuclear localization for hUBE3A-Iso3 p.Met21Ala to a predominant cytosolic localization of the Kozak optimized hUBE3A-Iso3 KOZAK , while their mouse orthologues mUBE3A-Iso2 p.Met22Ala and mUBE3A-Iso2 KOZAK both localized predominantly to the cytosol. Taken together, these experiments indicate that the localization of human UBE3A-Iso3 is highly sensitive to amino acid substitutions at the p.Met21 position and that variants at this position not only abrogate the translation of hUBE3A-Iso1, but can also change the localization of hUBE3A-Iso3.
Open AccessLocalization of Human UBE3A Isoform 3 is Highly Sensitive to Amino Acid Substitutions at p.Met21 Position
UBE3A encodes three isoforms of Ubiquitin E3 ligase A, which differ in their N-terminal sequence, abundance, and localization. Recently, three individuals diagnosed with Angelman Syndrome have been described who carry a variant that abrogates the start codon of the predominant nuclear isoform 1 (hUBE3A-Iso1 p.Met1Thr ) and concomitantly results in a missense variant in isoform 3 (hUBE3A-Iso1 p.Met21Thr ), which we previously reported to be nuclear enriched as well. Here, we studied the effect of the p.Met21Thr variant on hUBE3A-Iso3 localization. Recombinant expression of hUBE3A-Iso3 p.Met21Thr in U2-OS and mouse neurons revealed similar UBE3A labelling in the nucleus and cytosol, indicating hUBE3A-Iso3 localization is sensitive to amino acid changes at this position. This finding prompted us to revisit hUBE3A-Iso3 localization, since we previously introduced a p.Met21Ala/p.Met22Ala amino acid substitution in hUBE3A-Iso3 and its mouse orthologue mUBE3A-Iso2 to prevent translation of the shorter hUBE3A-Iso1 and mUBE3A-Iso3 nuclear isoforms. Introduction of silent mutations to disfavour translation of the short UBE3A isoforms enabled us to determine the localization hUBE3A-Iso3 and mUBE3A-Iso2 in the absence of amino acid changes at the p.Met21/p.Met22 position, respectively. Surprisingly, hUBE3A-Iso3 localization shifted from predominant nuclear localization for hUBE3A-Iso3 p.Met21Ala to a predominant cytosolic localization of the Kozak optimized hUBE3A-Iso3 KOZAK , while their mouse orthologues mUBE3A-Iso2 p.Met22Ala and mUBE3A-Iso2 KOZAK both localized predominantly to the cytosol. Taken together, these experiments indicate that the localization of human UBE3A-Iso3 is highly sensitive to amino acid substitutions at the p.Met21 position and that variants at this position not only abrogate the translation of hUBE3A-Iso1, but can also change the localization of hUBE3A-Iso3.